Poietis develops and produces customized human tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Poietis mission is to provide solutions leveraging a proprietary, innovative Next-Generation Bioprinting platform and bring Tissue Engineering therapies to patients.

The cinoany is a spin-off from INSERM and University of Bordeaux where Laser-Assisted Bioprinting Technology was initially developed.

Next-Generation Bioprinting (NGB) platform aims to give tissue engineers and researchers greater freedom in the choice of biomaterials and hydrogels and greater versatility in their research and development.

Poietis has been developing a therapeutic pipeline of several tissue products for wound healing and other applications.